Filing Details

Accession Number:
0001484612-21-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-02 17:28:30
Reporting Period:
2021-06-01
Accepted Time:
2021-06-02 17:28:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484612 Outset Medical Inc. OM Electromedical & Electrotherapeutic Apparatus (3845) 200514392
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1823380 Martin Vazquez 3052 Orchard Drive
San Jose CA 95134
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-01 5,000 $3.88 14,255 No 4 M Direct
Common Stock Disposition 2021-06-01 5,000 $47.91 9,255 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-06-01 5,000 $0.00 5,000 $3.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
84,489 2027-12-19 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14. 2020.
  2. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.45 to $48.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting period.